Loading insider details...
Latest Form 4 (Jun 29, 2026): Grant/Award of 5,860 ALGS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Aligos Therapeutics, Inc. (ALGS) | Grant/Award | 5,860 | n/a |
| Dec 10, 2025 | Adverum Biotechnologies, Inc. (ADVM) | Tender of Shares | 10,333 | n/a |
| Jun 26, 2025 | Aligos Therapeutics, Inc. (ALGS) | Grant/Award | 5,860 | n/a |
| Jun 20, 2025 | Adverum Biotechnologies, Inc. (ADVM) | Grant/Award | 10,450 | n/a |
| Jun 28, 2024 | Aligos Therapeutics, Inc. (ALGS) | Grant/Award | 60,000 | n/a |
| Jun 20, 2024 | Adverum Biotechnologies, Inc. (ADVM) | Grant/Award | 10,520 | n/a |
| Feb 28, 2024 | Aligos Therapeutics, Inc. (ALGS) | Disposition to Issuer | 30,000 | n/a |
| Feb 9, 2024 | Adverum Biotechnologies, Inc. (ADVM) | Purchase | 100,000 | $135.0K |
| Oct 27, 2023 | Aligos Therapeutics, Inc. (ALGS) | Grant/Award | 183,083 | $138.6K |
| Jul 21, 2023 | Aligos Therapeutics, Inc. (ALGS) | Grant/Award | 20,000 | n/a |